Association of IL-10 and IL-10Rβ gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor
Tóm tắt
Extensive allelic matching in the human leukocyte antigen (HLA) genes is regarded as a prerequisite for good clinical success of allogeneic haematopoietic stem cell transplantation (HSCT). Also other genetic factors can be assumed to play a role in preventing and controlling the complications associated with allogeneic HSCT, in particular graft-versus-host disease (GvHD). Interleukin-10 (IL-10) and its receptor (IL-10R), key regulators of the immune response, are among these candidates. We studied the association of IL-10 and IL-10Rβ gene polymorphisms with the occurrence of GvHD in 309 HLA-identical sibling donor and recipient pairs.
The difference in genotypic IL-10 production between patient and donor in combination with patient IL-10Rβ A/A genotype predisposed strongly to acute GvHD (OR = 7.15, p = 0.000023). On the other hand, a combination of same genotypic IL-10 production with patient IL-10Rβ A/A genotype protected from chronic GvHD (OR = 0.407, p = 0.0097).
Our results suggest that IL-10 and IL-10Rβ genes have a synergistic effect on the risk of GvHD.
Từ khóa
Tài liệu tham khảo
Petersdorf EW: HLA matching in allogeneic stem cell transplantation. Current Opinion in Hematology. 2004, 11: 386-391. 10.1097/01.moh.0000143701.88042.d9.
Velardi A, Ruggeri L, Capanni M, Mancusi A, Perruccio K, Aversa F, Martelli MF: Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. Hematol J. 2004, 5 (Suppl 3): S87-S90. 10.1038/sj.thj.6200429.
Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E: Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol. 2004, 127: 479-490. 10.1111/j.1365-2141.2004.05216.x.
Bonnet D, Warren EH, Greenberg PD, Dick JE, Riddell SR: CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc Natl Acad Sci USA. 1999, 96: 8639-8644. 10.1073/pnas.96.15.8639.
Moore KW, de Waal MR, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001, 19: 683-765. 10.1146/annurev.immunol.19.1.683.
Kim DH, Lee NY, Sohn SK, Baek JH, Kim JG, Suh JS, Lee KB, Shin IH: IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation. 2005, 79: 1615-1622. 10.1097/01.TP.0000159792.04757.D4.
Lin MT, Storer B, Martin PJ, Tseng LH, Grogan B, Chen PJ, Zhao LP, Hansen JA: Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood. 2005, 106: 3995-4001. 10.1182/blood-2004-11-4338.
Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A: IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. Human Immunology. 2005, 66: 700-710. 10.1016/j.humimm.2005.02.003.
Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM: Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999, 94: 3941-3946.
Akdis CA, Blaser K: Mechanisms of interleukin-10-mediated immune suppression. Immunology. 2001, 103: 131-136. 10.1046/j.1365-2567.2001.01235.x.
Nolan KF, Strong V, Soler D, Fairchild PJ, Cobbold SP, Croxton R, Gonzalo JA, Rubio A, Wells M, Waldmann H: IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J Immunol. 2004, 172: 2201-2209.
Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol. 1993, 11: 165-190. 10.1146/annurev.iy.11.040193.001121.
Reitamo S, Remitz A, Tamai K, Uitto J: Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest. 1994, 94: 2489-2492. 10.1172/JCI117618.
Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H: The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol. 2004, 76: 314-321. 10.1189/jlb.0204117.
Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D: Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001, 72: 699-706. 10.1097/00007890-200108270-00024.
Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA: Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation. New England Journal of Medicine. 2003, 349: 2201-2210. 10.1056/NEJMoa022060.
Cavet J, Dickinson AM, Norden J, Taylor PRA, Jackson GH, Middleton PG: Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood. 2001, 98: 1594-1600. 10.1182/blood.V98.5.1594.
Bertinetto FE, Dall'Omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, et al.: Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. International Journal of Immunogenetics. 2006, 33: 375-384. 10.1111/j.1744-313X.2006.00630.x.
Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, et al.: Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood. 2001, 97: 3380-3389. 10.1182/blood.V97.11.3380.
Olkinuora H, Talvensaari K, Kaartinen T, Siitonen S, Saarinen-Pihkala U, Partanen J, Vettenranta K: T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant. 2007, 39: 149-156. 10.1038/sj.bmt.1705557.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED: 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995, 15: 825-828.
Tseng LH, Chen PJ, Lin MT, Singleton K, Martin EG, Yen AH, Chuang SM, Martin PJ, Hansen JA: Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFalpha and TNFbeta genes. Tissue Antigens. 2002, 59: 280-286. 10.1034/j.1399-0039.2002.590405.x.
Woolley N, Mustalahti K, Maki M, Partanen J: Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population. Scandinavian Journal of Immunology. 2005, 61: 51-56. 10.1111/j.0300-9475.2005.01525.x.
Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C: Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation. 2003, 75: 711-717. 10.1097/01.TP.0000055216.19866.9A.
Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P: Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999, 42: 1101-1108. 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y.